Free Republic

The U.S. government and pharmaceutical companies are investing a substantial amount to develop new mRNA vaccines for infectious diseases and cancer, fueling a lucrative mRNA platform valued at $136.2 billion.A newly established White House program announced on Aug. 23 that it is granting a total of $25 million over three years to Emory University, Yale School of Medicine, and the University of Georgia to develop personalized therapeutic vaccines against cancers and emerging infections, similar to how COVID-19 mRNA vaccines target SARS-CoV-2. They aim to use mRNA—an essential element in COVID-19 vaccines developed to prevent SARS-CoV-2 infections—to program a unique class...

Rose Garden12:40 P.M. EDTTHE PRESIDENT:  Thank you very much.  Thank you very much.  It’s very hot today.  Please, sit down.  This is going to be a very hot one, and we apologize to everybody out there that’s going to suffer through it.  But you know what?  It’s better than bad weather.And it’s great to be in the Rose Garden.  I want to especially thank this group for joining us as we announce a historic groundbreaking initiative in our ongoing effort to rapidly develop and manufacture a coronavirus vaccine.We’re joined by Secretary Steven Mnuchin, Secretary Mark Esper, Secretary Alex Azar,...